We already know that the positive effects of iPPS
on OA are for whole of body for at least 80% of
patients. That is the beauty of Zilosul, no painful
injections into the affected joint, removing the
need in most cases for medical practitioners to
administer.
PS. I say “know”, because, their is already plenty
of circumstantial evidence to support that view.
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-187
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 10050 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |